A pilot study using neuropsychological testing from the Arimidex, Tamoxifen, Alone or in Combination (ATAC) trial showed that patients receiving hormone therapy performed lower on processing speed ...

Cognitive dysfunction has been considered as a morbid condition that may possibly result from aromatase inhibitor therapy, the standard treatment in postmenopausal, estrogen/progesterone receptor ...

Arimidex is an aromatase inhibitor ... in postmenopausal women with disease progression, following tamoxifen therapy. Casodex is an androgen-receptor inhibitor, indicated for use in combination ...